Companies / Semnur Pharmaceuticals, Inc.
Semnur Pharmaceuticals, Inc.
DECASMNRCIK 1913577
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Sep 23, 2025 | Scilex Holding Co 10% owner | Sell Open-market sale | Common Stock | $191.12M | -11.9M -6.17% | 181,804,849 | high |
| Sep 23, 2025 | Scilex Holding Co 10% owner | Sell Open-market sale | Common Stock | $8.88M | -555K -52.60% | 500,000 | medium |
| Apr 11, 2022 | Denali Capital Global Investments LLC 10% owner | Buy Open-market buy | Class A Ordinary Shares | $5.10M | +510K | 510,000 | high |
| Apr 11, 2022 | Xu Jiandong 10% owner | Buy Open-market buy | Class A Ordinary Shares | $5.10M | +510K | 510,000 | high |
| Jun 15, 2026 | Scilex Holding Co 10% owner | Other Other (per filing) | Common Stock | $0 | -7.0M -3.87% | 174,770,112 | low |
| May 21, 2022 | Xu Jiandong 10% owner | Other Sold to issuer | Class B Ordinary Shares | — | -94K -4.63% | 1,932,500 | low |
| May 21, 2022 | Denali Capital Global Investments LLC 10% owner | Other Sold to issuer | Class B Ordinary Shares | — | -94K -4.63% | 1,932,500 | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| SMNR | common | 81686G105 |
| DECA | ordinary | G6256B106 |
| DECA | unknown | 81686G113 |